D. E. Shaw & Co., Inc. Karuna Therapeutics, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $1.65 Million - $2.18 Million	10,000 Added 23.47%	52,600 $8.89 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $863,968 - $1.18 Million	4,900 Added 13.0%	42,600 $9.24 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $2.61 Million - $3.31 Million	16,200 Added 75.35%	37,700 $6.85 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $4.12 Million - $5.09 Million	21,500 New	21,500 $4.22 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.